European Respiratory Journal · 2001 · 196 citations · 15 references
PharmacyPharmacologyPharmacotherapyPulmonary Function TestingPulmonologyRespiratory PharmacotherapyAsthma ManagementAsthma PharmacotherapyBronchodilator TherapyCombination Inhaler TherapyInhalation Dosage FormsPeak Expiratory FlowAsthma Bronchodilator TherapyBudesonide TherapyCombination Bronchodilator TherapyForced Expiratory Volume AssessmentPeak Expiratory Flow IndexPeak Expiratory Flow ResponseSingle-inhaler TherapyTriple Inhaler Therapy
Budesonide/formoterol in a single inhaler was compared with budesonide alone, and with concurrent administration of budesonide and formoterol from separate inhalers, in patients with asthma, not controlled with inhaled glucocorticosteroids alone. In this 12-week, double-blind, randomized, double-dummy study, 362 adult asthmatics (forced expiratory volume in one second 73.8% of predicted, inhaled glucocorticosteroid dose 960 microg x day(-1)) received single inhaler budesonide/formoterol (Symbicort Turbuhaler) 160/4.5 microg, two inhalations b.i.d., or corresponding treatment with budesonide, or budesonide plus formoterol via separate inhalers. There was a greater increase in morning peak expiratory flow (PEF) with single-inhaler (35.7 L x min(-1)) and separate-inhaler (32.0 L x min(-1)) budesonide and formoterol, compared with budesonide alone (0.2 L x min(-1); p<0.001, both comparisons); the effect was apparent after 1 day (p<0.001 versus budesonide, both comparisons). Similarly, evening PEF, use of rescue medication, total asthma symptom scores and percentage of symptom-free days improved more with both single inhaler and separate inhaler therapy than with budesonide alone, as did asthma control days (approximately 15% more, p<0.001 versus budesonide, both comparisons, with a marked increase in the first week). All treatments were well tolerated and the adverse event profile was similar in all three treatment groups. It is concluded that single inhaler therapy with budesonide and formoterol is a clinically effective and well-tolerated treatment for patients with asthma that is not fully controlled by inhaled glucocorticosteroids alone.
15
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
Romain Pauwels · Arerugī/Arerugi · 1996 · 10.1K citations
Pharmacy, Chronic Disease Prevention, Preventive Medicine +10
Lung volumes and forced ventilatory flows
PH Quanjer, G J Tammeling, J. E. Cotes et al. · European Respiratory Journal · 1993 · 5.3K citations · Full text
Quanjer Ph, Tammeling Gj, Cotes Je et al. · PubMed · 1993 · 3.8K citations
Health Professions, Clinical Sciences, Internal Medicine +17
Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
Romain Pauwels, Claes-Göran Löfdahl, Dirkje S. Postma et al. · New England Journal of Medicine · 1997 · 1.5K citations · Full text
The Use of β-Agonists and the Risk of Death and near Death from Asthma
Walter O. Spitzer, Samy Suissa, Pierre Ernst et al. · New England Journal of Medicine · 1992 · 1.2K citations · Full text